2,300 Shares in McKesson Corporation $MCK Bought by Pensionfund Sabic

Pensionfund Sabic bought a new stake in McKesson Corporation (NYSE:MCK) during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm bought 2,300 shares of the company’s stock, valued at approximately $1,887,000.

Other institutional investors have also modified their holdings of the company. Obsidian Personal Planning Solutions LLC increased its holdings in shares of McKesson by 2.9% in the 3rd quarter. Obsidian Personal Planning Solutions LLC now owns 426 shares of the company’s stock worth $346,000 after acquiring an additional 12 shares during the period. IAM Advisory LLC boosted its stake in McKesson by 0.3% during the 3rd quarter. IAM Advisory LLC now owns 3,908 shares of the company’s stock valued at $3,019,000 after purchasing an additional 13 shares during the period. PDS Planning Inc grew its position in McKesson by 1.1% in the 3rd quarter. PDS Planning Inc now owns 1,209 shares of the company’s stock worth $934,000 after purchasing an additional 13 shares during the last quarter. Berkshire Asset Management LLC PA grew its position in McKesson by 4.6% in the 3rd quarter. Berkshire Asset Management LLC PA now owns 294 shares of the company’s stock worth $227,000 after purchasing an additional 13 shares during the last quarter. Finally, Goldstein Advisors LLC increased its stake in shares of McKesson by 4.4% in the third quarter. Goldstein Advisors LLC now owns 334 shares of the company’s stock valued at $258,000 after purchasing an additional 14 shares during the period. Institutional investors own 85.07% of the company’s stock.

Analysts Set New Price Targets

MCK has been the topic of a number of recent analyst reports. Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating on shares of McKesson in a report on Wednesday, December 10th. Robert W. Baird set a $968.00 target price on McKesson in a research report on Wednesday, January 14th. Leerink Partners reaffirmed an “outperform” rating and set a $1,085.00 target price on shares of McKesson in a research note on Thursday, March 5th. Wall Street Zen upgraded shares of McKesson from a “hold” rating to a “buy” rating in a research report on Sunday. Finally, Morgan Stanley reaffirmed an “overweight” rating and issued a $966.00 price target on shares of McKesson in a research note on Thursday, January 29th. Thirteen analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the stock. According to data from MarketBeat, McKesson has an average rating of “Moderate Buy” and an average target price of $960.93.

Insider Buying and Selling at McKesson

In other news, EVP Leann B. Smith sold 190 shares of the company’s stock in a transaction on Tuesday, February 17th. The shares were sold at an average price of $945.00, for a total value of $179,550.00. Following the transaction, the executive vice president directly owned 2,989 shares of the company’s stock, valued at approximately $2,824,605. This represents a 5.98% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, CAO Napoleon B. Rutledge, Jr. sold 328 shares of the company’s stock in a transaction dated Friday, February 6th. The stock was sold at an average price of $955.00, for a total value of $313,240.00. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 3,868 shares of company stock worth $3,743,820 over the last 90 days. 0.08% of the stock is currently owned by insiders.

McKesson Price Performance

MCK stock opened at $881.01 on Wednesday. The firm has a market capitalization of $107.91 billion, a P/E ratio of 25.34, a P/E/G ratio of 1.41 and a beta of 0.38. McKesson Corporation has a 52-week low of $637.00 and a 52-week high of $999.00. The company’s 50 day simple moving average is $905.89 and its 200-day simple moving average is $837.19.

McKesson (NYSE:MCK) last posted its quarterly earnings data on Wednesday, February 4th. The company reported $9.34 EPS for the quarter, topping analysts’ consensus estimates of $9.19 by $0.15. The firm had revenue of $106.16 billion during the quarter, compared to analyst estimates of $105.98 billion. McKesson had a net margin of 1.09% and a negative return on equity of 338.97%. The company’s revenue was up 11.4% on a year-over-year basis. During the same quarter last year, the business posted $8.03 EPS. McKesson has set its FY 2026 guidance at 38.800-39.200 EPS. Sell-side analysts predict that McKesson Corporation will post 32.77 EPS for the current fiscal year.

McKesson Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, April 1st. Investors of record on Monday, March 2nd will be given a dividend of $0.82 per share. The ex-dividend date of this dividend is Monday, March 2nd. This represents a $3.28 dividend on an annualized basis and a yield of 0.4%. McKesson’s payout ratio is presently 9.43%.

McKesson Profile

McKesson Corporation (NYSE: MCK) is a global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products and health care technology solutions. Founded in 1833 and headquartered in Irving, Texas, McKesson operates across the drug distribution and healthcare services value chain, connecting manufacturers, pharmacies, hospitals and health systems to help manage the movement of medicines and clinical supplies.

The company’s core activities include pharmaceutical wholesale distribution and logistics, specialty pharmacy services, and the provision of medical-surgical supplies to acute and non-acute care providers.